You searched for bevacizumab - MPR

Your search for bevacizumab returned 122 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Home remove

Your search for bevacizumab returned 122 results

Sort Results:

Relevant Recent
ASCO 2011

ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed Ovarian Cancer

The addition of bevacizumab to carboplatin and paclitaxel chemotherapy for the first-line treatment of women with ovarian cancer may offer benefit compared with standard chemotherapy alone, particularly for patients with more aggressive disease, investigators noted in a presentation during the American Society of Clinical Oncology's 2011 Annual Meeting.

ASCO: Continuing Avastin With 2nd-Line Chemo Ups Survival

Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) who have progressed after discontinuation of first-line bevacizumab and chemotherapy.

Tecentriq Combination Regimen Approved for Metastatic Non-Squamous NSCLC

The approval was based on data from the IMpower 150 trial, an open-label study involving 1202 patients with stage IV metastatic NSq NSCLC who had not received prior chemotherapy for metastatic disease, but could have received prior EGFR or ALK kinase inhibitor if appropriate, regardless of PD-L1 or T-effector gene status and ECOG performance status 0 or 1.